![Michael Jacobs](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Jacobs
Direktor/Vorstandsmitglied bei Custom Healthcare Ltd.
Profil
Michael Jacobs has worked as a Director at Custom Healthcare Ltd.
since 2017.
Aktive Positionen von Michael Jacobs
Unternehmen | Position | Beginn |
---|---|---|
Custom Healthcare Ltd.
![]() Custom Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Part of Cheremy Capital LLC, Custom Healthcare Ltd. is a pharmaceutical contract development and manufacturing organization (CDMO). Founded in 2001 and based in Hove, UK, the company covers the full spectrum of activities from process development through commercial manufacturing. The British company offers a wide range of industry-leading pharmaceutical CDMO services, from clinical to commercial, and are capable of taking compounds from clinical to commercial. Custom Healthcare holds licenses issued by the MHRA, including MIA, MIA(IMP), MS, WDA, and controlled drugs licenses (schedules II – V). The company's project management team ensures that a multidisciplinary team supports each project to deliver with excellence. | Direktor/Vorstandsmitglied | 26.09.2017 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Custom Healthcare Ltd.
![]() Custom Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Part of Cheremy Capital LLC, Custom Healthcare Ltd. is a pharmaceutical contract development and manufacturing organization (CDMO). Founded in 2001 and based in Hove, UK, the company covers the full spectrum of activities from process development through commercial manufacturing. The British company offers a wide range of industry-leading pharmaceutical CDMO services, from clinical to commercial, and are capable of taking compounds from clinical to commercial. Custom Healthcare holds licenses issued by the MHRA, including MIA, MIA(IMP), MS, WDA, and controlled drugs licenses (schedules II – V). The company's project management team ensures that a multidisciplinary team supports each project to deliver with excellence. | Health Technology |